Immunic, Inc.

IMUX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2017 FY2016 FY2015 FY2014 FY2013
Assets
Cash & Equivalents $56.9M $60.0M $83.4M $102.2M $38.2M
Accounts Receivable — — — — —
Inventory — — — — —
Total Current Assets $58.1M $61.5M $85.1M $104.8M $43.9M
Property, Plant & Equipment $2.2M $2.5M $3.8M $3.1M $2.5M
Goodwill — — — — —
Intangible Assets (Excl. Goodwill) — — — — —
Total Assets $60.4M $64.0M $89.1M $108.1M $46.6M
Liabilities
Accounts Payable $1.0M $780.0K $1.2M $1.2M $1.2M
Total Current Liabilities $10.3M $5.5M $6.7M $10.3M $7.4M
Long-Term Debt — — — — —
Total Liabilities $73.7M $5.6M $6.8M $10.5M $91.2M
Stockholders' Equity
Retained Earnings $-296.0M $-243.8M $-202.9M $-150.8M $-103.2M
Total Stockholders' Equity $-13.3M $58.4M $82.3M $97.6M $-44.7M
← Newer Page 2 of 2 Older →